Skip to main content

Anji Pharmaceuticals

Cambridge, United States

Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics.

$70.0M raised
Sep 2021
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Anji Pharmaceuticals

How much funding has Anji Pharmaceuticals raised?
Anji Pharmaceuticals has raised $70.0M in total funding. The most recent round was Series B. The last funding was announced in September 2021.
Who are Anji Pharmaceuticals's investors?
Anji Pharmaceuticals's investors include Kaitai Capital, JMCR Partners, Viva Ventures Biotech Fund, Viva BioInnovator, Xiamen Changrong Investment Management.
Where is Anji Pharmaceuticals headquartered?
Anji Pharmaceuticals is headquartered in Cambridge, United States.
What does Anji Pharmaceuticals do?
Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics.
What stage is Anji Pharmaceuticals at?
Anji Pharmaceuticals is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Anji Pharmaceuticals — Funding & Investors." VCBacked, September 28, 2021, https://www.vcbacked.co/company/anji-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2021). Anji Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/anji-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Anji Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/anji-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .